Renaissance Technologies’s BRAINSTORM CELL THERAPUTC BCLI Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-13,573
| Closed | -$41K | – | 3738 |
|
|
2023
Q3 | $41K | Sell |
13,573
-214
| -2% | -$646 | ﹤0.01% | 3433 |
|
|
2023
Q2 | $426K | Buy |
+13,787
| New | +$426K | ﹤0.01% | 2961 |
|
|
2023
Q1 | – | Sell |
-787
| Closed | -$19K | – | 3975 |
|
|
2022
Q4 | $19K | Sell |
787
-2,926
| -79% | -$70.6K | ﹤0.01% | 3970 |
|
|
2022
Q3 | $246K | Buy |
3,713
+2,573
| +226% | +$170K | ﹤0.01% | 3289 |
|
|
2022
Q2 | $47K | Buy |
+1,140
| New | +$47K | ﹤0.01% | 4003 |
|
|
2021
Q3 | – | Sell |
-3,173
| Closed | -$181K | – | 3472 |
|
|
2021
Q2 | $181K | Buy |
+3,173
| New | +$181K | ﹤0.01% | 3265 |
|
|
2021
Q1 | – | Sell |
-1,827
| Closed | -$124K | – | 3308 |
|
|
2020
Q4 | $124K | Buy |
+1,827
| New | +$124K | ﹤0.01% | 3229 |
|
|
2020
Q3 | – | Sell |
-9,416
| Closed | -$1.58M | – | 3375 |
|
|
2020
Q2 | $1.58M | Sell |
9,416
-29,027
| -76% | -$4.88M | ﹤0.01% | 2309 |
|
|
2020
Q1 | $2.68M | Buy |
38,443
+16,181
| +73% | +$1.13M | ﹤0.01% | 1902 |
|
|
2019
Q4 | $1.43M | Buy |
22,262
+2,453
| +12% | +$157K | ﹤0.01% | 2471 |
|
|
2019
Q3 | $1.16M | Buy |
19,809
+4,851
| +32% | +$284K | ﹤0.01% | 2536 |
|
|
2019
Q2 | $886K | Buy |
14,958
+1,448
| +11% | +$85.8K | ﹤0.01% | 2735 |
|
|
2019
Q1 | $880K | Buy |
13,510
+1,346
| +11% | +$87.7K | ﹤0.01% | 2724 |
|
|
2018
Q4 | $648K | Buy |
12,164
+3,237
| +36% | +$172K | ﹤0.01% | 2764 |
|
|
2018
Q3 | $511K | Buy |
8,927
+1,234
| +16% | +$70.6K | ﹤0.01% | 2840 |
|
|
2018
Q2 | $450K | Buy |
7,693
+1,753
| +30% | +$103K | ﹤0.01% | 2862 |
|
|
2018
Q1 | $281K | Sell |
5,940
-1,697
| -22% | -$80.3K | ﹤0.01% | 3100 |
|
|
2017
Q4 | $449K | Buy |
7,637
+6,100
| +397% | +$359K | ﹤0.01% | 2912 |
|
|
2017
Q3 | $95K | Buy |
+1,537
| New | +$95K | ﹤0.01% | 3083 |
|